Intelligence Hub
Market analytics and operational performance indicators
Current Report - November 9, 2021
Adoption of Executive Severance Plan for CEO and key officers.
Brief
Rocket Lab's compensation committee approved the Executive Severance Plan on November 3, 2021, for named executive officers including CEO Peter Beck, CFO Adam Spice, and EVP Shaun O’Donnell. The plan outlines severance payments upon qualifying terminations, with enhanced benefits during change-in-control periods including lump sums, health contributions, and equity acceleration. New forms of equity award agreements under the 2021 Stock Option Plan were also adopted.
Detailed Brief
On November 3, 2021, the compensation committee of Rocket Lab USA, Inc. approved the Executive Severance Plan, applicable to named executive officers upon execution of participation agreements. Outside a change-in-control (CIC) period, eligible executives receive 12 months base salary continuation and 12 months health contributions for CEO Peter Beck, or 6 months each for Tier 2 officers Adam Spice (CFO) and Shaun O’Donnell (EVP Global Operations), paid in installments subject to release and covenants. Within the CIC period (1 year post-CIC), benefits shift to lump sums: 150% base salary plus target bonus for CEO (plus 18 months health), 100% for Tier 2 (plus 12 months health), with full acceleration of time-based equity vesting (performance awards at target). CIC benefits include 280G mitigation to optimize after-tax value. Concurrently, new standard forms for RSUs, RSAs, NSOs, and ISOs were adopted for employees and non-employee directors under the 2021 plan. This filing under Item 5.02(e) reflects routine post-SPAC governance enhancements.
Key Telemetry
- • Compensation committee approved Severance Plan Nov 3, 2021, for CEO Peter Beck and Tier 2: CFO Adam Spice, EVP Shaun O’Donnell.
- • Outside CIC: CEO 12 months salary + health; Tier 2 6 months each.
- • In CIC: CEO 150% salary + bonus lump sum + 18 mo health + equity accel; Tier 2 100% + 12 mo health + accel.
- • New equity award forms (RSU, RSA, NSO, ISO) adopted for 2021 Incentive Plan.
- • All benefits require release of claims and covenant compliance; 280G parachute mitigation.
Impact Vector
Adoption standardizes executive severance post-IPO, promoting retention amid Rocket Lab's growth in launches and Neutron development. No immediate financial hit as contingent on terminations; CIC terms align interests in M&A scenarios. Positive for governance transparency; investors should view as neutral to mildly positive, with no dilution from new forms.